<span style="font-size:16px;">Recently, Jingtai technology, an artificial intelligence drug R & D company, and PerfXLab committed to the research and development of basic computing software jointly announced that the two sides have reached a long-term strategic cooperation to jointly explore new drug R & D technologies combining artificial intelligence (AI) and high-performance computing (HPC).</span> <div style="width:100%;text-align:center;">  </div> <span style="font-size:16px;"> PerfXLab is a company engaged in the research and development of basic computing software. It is committed to providing technical services and related software products of high-performance computing library and heterogeneous computing software stack for computing hardware technology enterprises, and providing an efficient and agile development environment for all kinds of high-performance computing applications. The core team members of the company are from the Chinese Academy of Sciences. They have the national leading technical ability and knowledge precipitation in the field of high-performance computing, and have established close cooperative relations with excellent computing technology enterprises at home and abroad. At the same time, the company vigorously advocates the concept of open source development and jointly promotes the application ecology construction of high-performance computing with partners. As one of the world's leading artificial intelligence drug R & D companies, Jingtai technology has established a complete set of AI drug discovery process, closely combined digital R & D tools, advanced experimental ability with the domain knowledge of the expert team, created a new foundation for AI enabled drug R & D, and served nearly 100 biomedical enterprises and R & D institutions around the world. Founded by a group of quantum physicists and drug R & D experts, Jingtai technology has always focused on the innovation of underlying technology, solved the bottleneck problems of speed, scale, innovation and success rate in drug research, and enabled the source innovation of biomedicine with technological innovation. Through cooperation, PerfXLab will rely on the self-developed perfxapi heterogeneous computing software stack to provide Jingtai technology with hardware acceleration schemes and various computing hardware platforms for adaptation and efficient programming models. The two sides will conduct in-depth and long-term cooperation around the innovation of HPC + AI in the drug R & D industry, challenge the efficiency bottleneck of traditional R & D, enable new drug R & D to achieve a breakthrough in innovation speed and scale, jointly explore accelerated computing technology in the "Ai pharmaceutical field", help pharmaceutical companies greatly improve the speed and accuracy of drug R & D, and enable the transformation and upgrading of traditional pharmaceutical industry. </span> <div style="width:100%;text-align:center;">  <span style="font-size:16px;">Junhui Wang</span> </div> <span style="font-size:16px;">For this cooperation, Junhui Wang, co-founder and chief operating officer of PerfXLab, said: "China's leading high-performance heterogeneous computing acceleration expert" and "the world's leading quantum physics and drug R & D expert" will promote revolutionary changes in the field of drug R & D through cross domain and interdisciplinary close cooperation. "</span> <div style="width:100%;text-align:center;">  <span style="font-size:16px;">Lipeng Lai</span> </div> <span style="font-size:16px;">Co founder of Jingtai technology, Dr. Lipeng Lai, head of artificial intelligence R & D center, commented: "New drug R & D is a long-term and complex system engineering. The implementation of AI and high-precision computational chemistry technology in drug R & D is inseparable from the continuous improvement of computing efficiency. We hope that this cooperation can accelerate AI and computing through the continuous development and innovation of software and hardware, and finally benefit the related drug R & D fields. Jingtai technology and pengfeng technology The existing good trust has laid a foundation for this cooperation and longer-term cooperation in the future. I believe that the leading artificial intelligence drug R & D platform of Jingtai technology and pengfeng technology will bring new opportunities for traditional drug R & D, which is of great value to both of us. "</span> **<span style="font-size:20px;">About PerfXLab</span>** <span style="font-size:16px;">PerfXLab was established in 2016 by Zhang Xianyi (Doctor of Chinese Academy of Sciences, initiator of OpenBLAS open source project, member of CCF High Performance Computing Committee). The core team members of the company come from the Chinese Academy of Sciences and are committed to accelerating the research of computing technology. (Calculation library, parallel optimization, calculation engine and domain compiler, etc.), empowering the three major areas of HPC, AI and RISC-V. At the same time, the company vigorously advocates the concept of open source development, and works with partners to promote the ecological construction of basic software in my country.</span> **<span style="font-size:20px;">About Jingtai Technology</span>** <span style="font-size:16px;">Jingtai Technology is a drug research and development company empowered by quantum physics and artificial intelligence. It is committed to realizing industry innovation in drug research and development by improving the speed, scale, innovation and success rate of drug research and development. As a company based in China and the United States and serving the world, Jingtai Technology always insists on exploring the best solutions to make full use of cutting-edge R&D and computing resources to maximize the needs of customers and partners. Jingtai Technology's smart drug R&D platform will integrate cloud-based super-computing digital R&D tools with advanced experimental capabilities to form a R&D system with high-precision predictions and targeted experiments that mutually confirm and guide each other. As one of the world's pioneering artificial intelligence drug research and development companies, Jingtai Technology has established a complete set of R&D iterative processes that closely integrate quantum physics dry laboratories and advanced wet laboratories to challenge the efficiency bottlenecks of traditional R&D and enable new drug R&D to achieve innovation speed Breakthrough with scale.</span> ---